Single Institution Assessment of Compliance with Guideline Directed Aspirin Therapy in the Prevention of Colorectal Cancer in Lynch Syndrome

Abstract excerpt

<title>Abstract</title> <p> <bold>Background</bold> : Patients with Lynch syndrome (LS) have been shown to have up to an 80% lifetime risk of developing colorectal cancer. The National Comprehensive Cancer Network (NCCN) guidelines recommend LS patients consider taking aspirin daily to reduce their risk of colorectal cancer, which is primarily based on the Cancer Prevention Project 2 (CAPP-2) study results. In...

Topics

Open a Topic to create a Post that cites this publication.

• Colonic Neoplasms
• Colonoscopy
• Colorectal Neoplasms, Hereditary Nonpolyposis
• Decision Support Techniques
• DNA Mismatch Repair
• Genetic factors in colorectal cancer
• Microsatellite Instability
• Mutation

Identifiers and source

Literature Corpus work

984d024e-0a8c-5e44-a350-5cb4c46166b3

DOI

10.21203/rs.3.rs-7189423/v1